Evidence map›Paper›PMID 34894974›Full record

SynthesisExpert review of neurotherapeutics2022

Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion.

Susanna B Park, Stefano Tamburin, Angelo Schenone, Ian R Kleckner, Roser Velasco, Paola Alberti, Grace Kanzawa-Lee, Maryam Lustberg, Susan G Dorsey, Elisa Mantovani and 5 more

Open access · greenAbstract readSystematic ReviewConsensus Statement
In one paragraph

Synthesis in Expert review of neurotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  4. Article
  5. Incidence and associated factors of falls in patients with chemotherapy-induced peripheral neuropathy: a scoping review and evidence mapping.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  6. Article
  7. Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  8. Article
  9. Exploring the reliability and validity of clinically-relevant outcome measures for chemotherapy-induced peripheral neuropathy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  10. Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 5 countries.

Susanna B ParkFaculty of Medicine and Health, School of Medical Sciences, Brain and Mind Centre, the University of Sydney, Sydney, Australia.ORCID 0000-0003-0218-4707
Stefano TamburinDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Angelo SchenoneDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (Dinogmi), University of Genoa, Genoa, Italy.
Ian R KlecknerDepartment of Surgery, University of Rochester Medical Center, Rochester, NY, USA.
Roser VelascoNeurology Department, Neuro-Oncology Unit-IDIBELL, Hospital Universitari de Bellvitge-Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain.
Paola AlbertiExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.ORCID 0000-0001-6106-6183
Grace Kanzawa-LeeDepartment of Health Behavior and Biological Sciences, University of Michigan School of Nursing, Ann Arbor, Michigan, USA.
Maryam LustbergYale Breast Center and Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Susan G DorseyDepartment of Pain & Translational Symptom Science, University of Maryland, Baltimore Maryland, USA.
Elisa MantovaniDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Mehrnaz HamedaniDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (Dinogmi), University of Genoa, Genoa, Italy.
Andreas A ArgyriouDepartment of Neurology, "Saint Andrew's" State General Hospital of Patras, Patras, Greece.ORCID 0000-0003-2131-7114
Guido CavalettiExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.ORCID 0000-0003-4128-2406
Ahmet HokeDepartment of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-1215-3373
Toxic Neuropathy Consortium
University of Milano-Bicocca · ITUniversity of Verona · ITGeneral University Hospital of Patras · GRJohns Hopkins University · USOspedale Policlinico San Martino · ITThe University of Sydney · AUUniversitat Autònoma de Barcelona · ESUniversity of Genoa · ITUniversity of Maryland, Baltimore · USUniversity of Michigan · USUniversity of Rochester Medical Center · USYale Cancer Center · US

Funding

The Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy, Inflammation, and Interoceptive Brain CircuitryK07CA221931 · NCI · UNIVERSITY OF ROCHESTER · PI KLECKNER, IAN ROBERT · 2018 to 2022
$795k
Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathyR21CA256154 · NCI · UNIVERSITY OF ROCHESTER · PI KLECKNER, IAN ROBERT, LIN, PO-JU · 2021 to 2021
$351k
NCI NIH HHS K07 CA221931
6 · The paper itself

Abstract

introductionChemotherapy-induced peripheral neurotoxicity (CIPN) remains a significant toxicity in cancer survivors without preventative strategies or rehabilitation. Exercise and physical activity-based interventions have demonstrated promise in reducing existing CIPN symptoms and potentially preventing toxicity, however there is a significant gap in evidence due to the lack of quality clinical trials and appropriate outcome measures. AREAS COVERED: We systematically reviewed outcome measures in CIPN exercise and physical rehabilitation studies with expert panel consensus via the Peripheral Nerve Society Toxic Neuropathy Consortium to provide recommendations for future trials. Across 26 studies, 75 outcome measures were identified and grouped into 16 domains within three core areas - measures of manifestations of CIPN (e.g. symptoms/signs), measures of the impact of CIPN and other outcome measures. EXPERT OPINION: This article provides a conceptual framework for CIPN outcome measures and highlights the need for definition of a core outcome measures set. The authors provide recommendations for CIPN exercise and physical rehabilitation trial design and outcome measure selection. The development of a core outcome measure set will be critical in the search for neuroprotective and treatment approaches to support cancer survivors and to address the gap in the identification of effective rehabilitation and treatment options for CIPN.

Indexed as

Antineoplastic AgentsNeoplasmsPeripheral Nervous System DiseasesExerciseHumansOutcome Assessment, Health CareAntineoplastic Agentscancer survivorshipChemotherapy induced peripheral neurotoxicityexerciseneurotoxicityoutcome measuresperipheral neuropathyrehabilitationtreatment

Identifiers

PMID34894974
PMCPMC8963967
OpenAlexW4200478766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.